Headlands Technologies’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-12,630
Closed -$516K 1623
2024
Q2
$516K Buy
12,630
+12,019
+1,967% +$491K 0.05% 272
2024
Q1
$25.8K Buy
+611
New +$25.8K 0.01% 863